Literature DB >> 9458814

Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP.

C B Allen1, C W White.   

Abstract

To determine whether glucose depletion is a principal determinant of hyperoxic cell death in vitro, human lung epithelial-like cells (A549) were exposed to hyperoxia (95% O2) in either 10, 30, or 50 ml of medium (Ham's F-12K). Glucose was depleted in the medium after 36, 60, or 96 h, respectively. Medium lactate dehydrogenase (LDH) activity increased only after glucose was depleted. To confirm that glucose depletion was critical to cell death, cells exposed to 95% O2 were supplemented with glucose at regular intervals to reestablish initial medium glucose concentrations. Other cells received no supplements. Without supplementation, glucose was depleted within 48 h, followed within 12 h by an almost complete loss of cell ATP and elevated medium LDH activity. Glucose-supplemented cells appeared normal microscopically and did not release LDH activity despite an extracellular pH of 6.5 due to fermentation. Additional experiments at sea-level pressure confirmed that glucose supplementation prevents extensive cell death in hyperoxia in cultured A549 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458814     DOI: 10.1152/ajplung.1998.274.1.L159

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Surface fluorescence studies of tissue mitochondrial redox state in isolated perfused rat lungs.

Authors:  Kevin Staniszewski; Said H Audi; Reyhaneh Sepehr; Elizabeth R Jacobs; Mahsa Ranji
Journal:  Ann Biomed Eng       Date:  2012-12-13       Impact factor: 3.934

2.  Differential responses of targeted lung redox enzymes to rat exposure to 60 or 85% oxygen.

Authors:  Zhuohui Gan; David L Roerig; Anne V Clough; Said H Audi
Journal:  J Appl Physiol (1985)       Date:  2011-05-05

Review 3.  Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.

Authors:  Haifeng Zhao; Phyllis A Dennery; Hongwei Yao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

4.  Gene expression profile of human airway epithelium induced by hyperoxia in vivo.

Authors:  Arnaud Chambellan; Paul J Cruickshank; Patrick McKenzie; Steven B Cannady; Katalin Szabo; Suzy A A Comhair; Serpil C Erzurum
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-11       Impact factor: 6.914

5.  Biphasic response of checkpoint control proteins in hyperoxia: exposure to lower levels of oxygen induces genome maintenance genes in experimental baboon BPD.

Authors:  Kumuda C Das; John D Wasnick
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

6.  Hyperoxia decreases glycolytic capacity, glycolytic reserve and oxidative phosphorylation in MLE-12 cells and inhibits complex I and II function, but not complex IV in isolated mouse lung mitochondria.

Authors:  Kumuda C Das
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

7.  Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Authors:  Li Yue; Xuexin Lu; Phyllis A Dennery; Hongwei Yao
Journal:  Redox Biol       Date:  2021-08-13       Impact factor: 11.799

8.  Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.

Authors:  Amit Kulkarni; Kumuda C Das
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-03-14       Impact factor: 5.464

9.  Metabolic pathway for the universal fluorescent recognition of tumor cells.

Authors:  Ana Fernandez-Carrascal; Manuel Garcia-Algar; Moritz Nazarenus; Alicia Torres-Nuñez; Luca Guerrini; Neus Feliu; Wolfgang J Parak; Eduardo Garcia-Rico; Ramon A Alvarez-Puebla
Journal:  Oncotarget       Date:  2017-06-16

10.  Short exposure to hyperoxia causes cultured lung epithelial cell mitochondrial dysregulation and alveolar simplification in mice.

Authors:  David Garcia; Jennifer F Carr; Felix Chan; Abigail L Peterson; Kimberlyn A Ellis; Alejandro Scaffa; Andrew J Ghio; Hongwei Yao; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2020-11-03       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.